To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
954 Current news from the industry diagnosticsrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
New method to support physicians in leukemia diagnostics
For the first time, researchers from Helmholtz Zentrum München and the University Hospital of LMU Munich show that deep learning algorithms perform similar to human experts when classifying blood samples from patients suffering from acute myeloid leukemia (AML). Their proof of concept study paves ...
Aggressive forms of breast cancer often manipulate the immune response in their favor. This manipulation is revealed in humans by the same immunological "signature" as in mice. This is shown by a study carried out by scientists from the University of Bonn together with Dutch colleagues. Their ...
Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny "decoy" implanted just beneath the skin, University of Michigan researchers have demonstrated in mice. These devices have a knack for attracting cancer cells traveling through ...
The focus on digital transformation is being further expanded
From March 31 to April 03, 2020, analytica will open its doors on the fairgrounds of Messe München. Even now there are already signs of an increase in the number of exhibitors. One focus of the world’s leading trade fair for laboratory technology, analysis and biotechnology with the accompanying ...
A study published in the Journal of Clinical Microbiology describes a new rapid assay for Lyme disease that could lead to a practical test for use by healthcare providers. The researchers found the assay, which uses several biomarkers to detect Lyme disease infection, was more sensitive than ...
In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease – up to 14 years before a clinical diagnosis was made. Amyloid-β folding proved to be superior to other risk markers evaluated, as shown by scientists ...
Researchers present a cost-effective machine for the production of microarrays
Microarrays are state-of-the-art tools in molecular biology that enable the rapid and parallel diagnosis of various diseases. Therefore, they are indispensable for the development of new vaccines. Like a computer chip, microarrays contain a lot of information in the smallest space. Microarrays ...
It is the 'silent killer' that claimed the life of Albert Einstein and affects 1% of men over the age of 65, but researchers at the University of Dundee believe they may be able to reduce the number of fatalities caused by abdominal aortic aneurysms. Aneurysms are the swelling and weakening of ...
Flexible, biocompatible nanocellulose sensors
Physiological parameters in our blood can be determined without painful punctures. Empa researchers are currently working with a Canadian team to develop flexible, biocompatible nanocellulose sensors that can be attached to the skin. The 3D-printed analytic chips made of renewable raw materials ...
Peer M. Schatz to step down as CEO
QIAGEN N.V. announced thatPeer M. Schatz, Chief Executive Officer, has notified the Company that, after 27 years at QIAGEN, he has decided to step down as Chief Executive Officer and Chairman of the Management Board. He will remain with QIAGEN as Special Advisor to the Supervisory Board and ...